CD274 and neoplasm: We hypothesized that PD-L1 expression levels in the tumor would increase in the early phase of chemotherapy and radiotherapy as a defense mechanism, resulting in increased [89Zr]Zr-durvalumab uptake, with a decrease in the later phase due to cancer cell destruction.